Emergent BioSolutions

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EBS and other ETFs, options, and stocks.

About EBS

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. 

CEO
Joseph C. Papa
CEOJoseph C. Papa
Employees
900
Employees900
Headquarters
Gaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded
1998
Founded1998
Employees
900
Employees900

EBS Key Statistics

Market cap
702.19M
Market cap702.19M
Price-Earnings ratio
10.74
Price-Earnings ratio10.74
Dividend yield
Dividend yield
Average volume
767.03K
Average volume767.03K
High today
$13.99
High today$13.99
Low today
$13.18
Low today$13.18
Open price
$13.81
Open price$13.81
Volume
1.05M
Volume1.05M
52 Week high
$14.06
52 Week high$14.06
52 Week low
$4.02
52 Week low$4.02

Stock Snapshot

Emergent BioSolutions(EBS) stock is priced at $13.42, giving the company a market capitalization of 702.19M. It carries a P/E multiple of 10.74.

During the trading session on 2026-01-09, Emergent BioSolutions(EBS) shares reached a daily high of $13.99 and a low of $13.18. At a current price of $13.42, the stock is +1.8% higher than the low and still -4.1% under the high.

Trading activity shows a volume of 1.05M, compared to an average daily volume of 767.03K.

Over the past 52 weeks, Emergent BioSolutions(EBS) stock has traded between a high of $14.06 and a low of $4.02.

Over the past 52 weeks, Emergent BioSolutions(EBS) stock has traded between a high of $14.06 and a low of $4.02.

EBS News

TipRanks 11h
Emergent BioSolutions receives $21.5M BioThrax order from Department of War

Emergent BioSolutions (EBS) announced it has received a delivery order valued at up to $21.5M from the U.S. Department of War to supply BioThrax in 2026. This o...

TipRanks 17h
Emergent BioSolutions: Strategic Infectious Disease Positioning and Countermeasure Demand Support Buy Rating and $15 Target

Emergent Biosolutions, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram Selvaraju from H.C. Wainwright reiterated a Buy...

TipRanks 19h
Emergent BioSolutions enters collaboration agreement with PANTHER

Emergent BioSolutions (EBS) announced a collaboration agreement with PANTHER to provide additional financial support to continue progressing the Africa CDC-led...

People also own

Based on the portfolios of people who own EBS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.